METHOD FOR IDENTIFYING PHARMACEUTICAL AGENTS FROM VEGETABLE EXTRACTS Russian patent published in 2005 - IPC

Abstract RU 2244751 C2

FIELD: genetic engineering, molecular biology, pharmacy.

SUBSTANCE: invention relates to methods of genome screening and can be used for identification of pharmacological agent in vegetable extract. Method is realized by treatment of cells with a vegetable extract, isolation of protein or RNA from these cells, identification of isolated protein or RNA wherein their concentration differs from that in untreated cells and detection of compound(s) in indicated vegetable extracts. Then cells are treated with the found compound(s), protein or RNA are isolated from cells treated with this compound(s) and compound(s) are identified that cause the stimulation or inhibition of expression of protein or RNA wherein their concentration differs from that in untreated cells. Invention provides carrying out the characterization of biological properties of vegetable extract and to detect the individual compound(s) that elicit unknown or disclosed biological property of this extract.

EFFECT: improved identifying method.

6 cl

Similar patents RU2244751C2

Title Year Author Number
METHOD FOR IDENTIFICATION OF PHARMACEUTICAL AGENTS FROM VEGETABLE EXTRACTS 1997
  • Bofur Al'Ber
  • Moro Zhak-P'Er
RU2251690C2
METHOD FOR DETECTING RADIATION OR RADIOMIMETIC CHEMICALS ACTION EARLIER EXERTED UPON MAMMALS 1996
  • Gong Dzhozef K.
  • Glomski Chester A.
RU2174686C2
GENE (LBFL313) FAMILY ASSOCIATED WITH MALIGNANT GROWTH OF PANCREAS 2007
  • Kokh Sang-Seok
  • Song Si-Joung
  • Kim Sun-A
  • Li Jang-Soon
  • Dzeon Sun-Bok
  • Park Eui-Chul
  • Kim Joung-Gun
RU2432399C2
STRESS-TOLERANT TRANSGENIC WHEAT PLANT 2005
  • Maknejl Skott Dehvid
  • Chehmberlejn Duglas Alan
  • Bauehr Robert Sindekom
RU2376377C2
DNA DETECTION METHODS FOR SITE-SPECIFIC NUCLEASE ACTIVITY 2013
  • Sastri-Dent Lakshmi
  • Simpson Mettyu
  • Tsao Tszekhuej
  • Chen Vej
  • Chzhou Nin
  • Uebb Stiven R.
RU2678001C2
FUSION PROTEIN CONTAINING THYMIC STROMAL LYMPHOPOIETIC PROTEIN, VACCINE CONTAINING EXPRESSION VECTOR FOR EXPRESSION OF PROTEINS AND VACCINE COMPRISING SAID EXPRESSION VECTOR 2012
  • Mattson Dzhanin D.
  • Gorman Daniel M.
  • De Vaal Mejlfit Rene
  • Morsi Mokhamad A.
RU2617957C2
POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION 2002
  • Ferrandi Ehrik
  • Kamara I Ferrer Khose-Antonio
  • Martine Zhan
  • Tjur'O Kristof
RU2307666C2
CANINE THYMIC STROMAL LYMPHOPOIETIN PROTEIN AND USE THEREOF 2007
  • Mattson Dzhanin D.
  • Gorman Daniehl' M.
  • De Vaal' Mejlfit Rene
  • Morsi Mokhamad A.
RU2457217C2
FARNESENE-SYNTHASE 2009
  • De Bot, Mikhil Jan
  • Skhjurink, Robert, Kornelis
  • Ament, Kaj
  • Kharing, Mikhaehl', Al'Bertus
RU2546877C2
DISEASE-RESISTANT PLANTS 2006
  • Gabriehl'S Sjuzan Kherma Ehlizabet Jokhanna
  • Vossen Jak Khjubertus
  • Josten Matt'E Khenri Anton Jozef
  • De Vit Peter Jozef Gerard Marie
RU2393227C2

RU 2 244 751 C2

Authors

Bofur Al'Ber

Moro Zhak-P'Er

Dates

2005-01-20Published

1997-11-05Filed